Amphastar Pharma (AMPH) Tops Q1 EPS by 2c

Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.09, $0.02 better than the analyst estimate of $0.07. Revenue for the quarter came in at $56.67 million versus the consensus estimate of $19.49 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• McGraw Hill (MH) Tops Q1 EPS by 15c, Beats on Revenue; Offers FY26 Revenue Guidance
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c